<DOC>
	<DOC>NCT01539408</DOC>
	<brief_summary>Women diagnosed with incomplete abortion in this health facility will be randomized to receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion with misoprostol using 400 mcg administered sublingually will be as effective as surgical evacuation.</brief_summary>
	<brief_title>Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Incomplete</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>no contraindications to misoprostol uterine size was not larger than 12 weeks there were no signs of severe infection haemodynamically stable in general good health willing to provide contact information an IUD in place ectopic pregnancy aged below 18 years and had no accompanying adult to provide informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>